Androgens and NAFLD Longitudinal Cohort Study
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT06124261
- Status
- Recruiting
Conditions
- NAFLD
- NASH
- PCOS
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 42 Years
- Healthy Volunteers
- Not accepted
Study Details
The researchers want to learn how androgens, a type of sex hormone, might affect nonalcoholic fatty liver (NAFLD) in young women over time. NAFLD happens when fat builds up in the liver which can cause damage to the liver such as inflammation or scarring. Young women with a condition called polycystic ovary syndrome (PCOS) have a high risk for NAFLD, and they often have high androgen levels too. So the researchers are recruiting young women with PCOS as well as those without PCOS, and will compare changes in NAFLD over time between young women with and without PCOS. This study is funded by the National Institutes of Health
Key Dates
- Start date
- Jan 22, 2024
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 150 participants (estimated)
Arms
- Arm: MASLD and PCOS hyperandrogenismPatients with MASLD and PCOS with the phenotype of hyperandrogenism
- Arm: MASLD and PCOS non-hyperandrogenismPatients with MASLD and PCOS with the phenotype of non-hyperandrogenism
- Arm: MASLD and no-PCOSPatients with metabolic dysfunction-associated steatotic liver disease (MASLD) and no PCOS
Primary Outcome Measure
Liver Stiffness Change [ Time Frame: from baseline to Year 3 follow- up. ]
Central Contacts
- Lily C Carbullido, B.S.415-502-3725
- Jasmine Gamez
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California San Francisco | San Francisco | California | 94143 | |
| Duke University | Durham | North Carolina | 27708 | Linda Perry, R.N. |
Find similar trials in San Francisco, CA
Related Studies
- Bicalutamide Therapy in Young Women With NAFLD and PCOSPHASE1 · Recruiting · University of California, San Francisco · San Francisco, California
- Accurate Point of Care Liver Disease Diagnostics (Phase 2)Recruiting · University of California, San Diego · La Jolla, California
- Reversal of Lipid-Induced Insulin ResistanceRecruiting · Yale University · New Haven, Connecticut
- Bariatric Embolization of Arteries for the Treatment of Nonalcoholic SteatohepatitisNot Yet Recruiting · Keith Pereira, MD: · St Louis, Missouri